Testicular cancer mortality in the Americas, 1980–2003

Bertuccio, Paola; Malvezzi, Matteo; Chatenoud, Liliane; Bosetti, Cristina; Negri, Eva; Levi, Fabio; Vecchia, Carlo La

doi:10.1002/cncr.22473

Cited by 29 publications

(9 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…With reference to testicular cancer the favourable trends observed in most European countries over the last decades are consistent with those observed in the United States (21,22) although with a substantial delay, particularly in central/eastern Europe. Testicular cancer is one of the most curable neoplasm, the favourable pattern in mortality is largely attributed to the introduction (since1970s)of effective treatments, mainly platinum-derived chemotherapy.…”

Section: Overuse Of Cigarettes Smoking and Testicular Cancersupporting

confidence: 73%

Overuse of Cigarettes Smoking and Link with Urologic Disease

2016

IJSR

View full text Add to dashboard Cite

Tobacco smoking is a major worldwide cause of morbidity and mortality from various diseases, including urologic diseases.Cigarettes smoking is a leading cause of death from cancer, although the relationship between Smoking and urologic cancer is controversial. Objective: To evaluate the available evidence of the role of the cigarette smoking and urologic disease development and progression, and to discuss possible clinical implication for Urologic Disease management. Material & Methods: A literature search was conducted to identify original articles, reviews, editorials, and international scientific congress abstracts(published in English language) combining the following terms: cigarette smoking, urogenital diseases, smokeless tobacco, tobacco cessation We selected articles according to predefined inclusion criteria and the Preferred Reporting Item for Systematic reviews and Meta-analysis. Results: Most of the studies demonstrated the link between Cigarette smoking and Urologic diseases. The association between cigarette smoking and Urologic diseases incidence is controversial, particularly in recent series. Current cigarette smoking is associated with an increased risk of Urologic diseases morbidity, and the number of cigarettes smoked per day a dose-response association with Urologic diseases mortality. Smokers present a high risk of biochemical or distant failure after urologic diseases treatment. Several biological mechanisms behind these association have been proposed, although the molecular mechanisms remain unclear. Further research is required to better understand the role of smoking of urologic cancer developing and progression and, particularly to evaluate the possible effect of smoking cessation on urologic malignant/non-malignant diseases management. Conclusion: Data from the PeerReviewed literature suggested an association of smoking and aggressive urologic cancer. Although the pathophysiology underling these association remains unclear. Smokers presented higher urologic cancer mortality and worse outcome after treatment. Smokingcessation counseling should be implemented for patient with urologic malignant/non-malignant diseases, although its effect on urologic cancer progression should be investigated.

show abstract

Section: Overuse Of Cigarettes Smoking and Testicular Cancersupporting

confidence: 73%

Overuse of Cigarettes Smoking and Link with Urologic Disease

2016

IJSR

View full text Add to dashboard Cite

show abstract

“…In Mexico, despite the favorable trend in HL mortality registered over the last decade, rates in 2007 were twofold higher than those registered in the United States, Brazil and Argentina, likely reflecting difficulties in the adoption of modern effective therapies. This delay in the adoption of effective treatments has also been observed for other curable cancers in the young, such as testicular cancer . Some delay in HL diagnosis in Mexico, in particular in children of the lower economic level, may also have influenced the mortality from this neoplasm and can be related to socioeconomic inequalities.…”

Section: Discussionmentioning

confidence: 91%

“…This delay in the adoption of effective treatments has also been observed for other curable cancers in the young, such as testicular cancer. 18,37,38 Some delay in HL diagnosis in Mexico, in particular in children of the lower economic level, may also have influenced the mortality from this neoplasm 39 and can be related to socioeconomic inequalities. In fact, income distribution in Mexico is very inequitable, with more than 40 million people below the poverty line.…”

Section: Discussionmentioning

confidence: 99%

Hodgkin's lymphoma mortality in the Americas, 1997–2008: Achievements and persistent inadequacies

Chatenoud

Bertuccio

Bosetti

et al. 2013

Intl Journal of Cancer

Self Cite

View full text Add to dashboard Cite

Although therapeutic advancements have made Hodgkin's lymphoma (HL) a largely curable disease, trends in HL mortality have been variable across countries. To provide updated information on HL mortality in the Americas, overall and 20–44 years age‐standardized (world population) mortality rates from HL were derived for the 12 Latin American countries providing valid data to the World Health Organization database and with more than two million of inhabitants. For comparative purpose, data for the United States and Canada were also presented. Trends in mortality over the 1997 to 2008 period are based on joinpoint regression analysis. Declines in HL mortality were registered in all Latin American countries except in Venezuela. In most recent years, HL mortality had fallen to about 0.3/100,000 men and 0.2/100,000 women in Argentina, Brazil, Chile, Colombia, Ecuador and Guatemala, that is, to values similar to North America. Despite some declines, rates remained high in Cuba (1/100,000 men and 0.7/100,000 women), Costa Rica and Mexico as well as in Venezuela (between 0.5 and 0.6/100,000 men and between 0.3 and 0.5/100,000 women). In young adults, trends were more favorable in all Latin American countries except Cuba, whose rates remained exceedingly high (0.8/100,000 men and 0.6/100,000 women). Thus, appreciable declines in HL mortality were observed in most Latin America over the last decade, and several major countries reached values comparable to North America. Substantial excess mortality was still observed in Cuba, Costa Rica, Mexico and Venezuela, calling for urgent interventions to improve HL management in these countries.

show abstract

“…Mortality from testicular cancer, Hodgkin's lymphomas, and leukemias, that is, some of the major neoplasms amenable to treatment, are not substantially higher in Brazil as compared with North America and other developed areas of the world (Bertuccio et al, 2007;Bosetti et al, 2009). If not largely due to underascertainment, this would suggest that adequate treatment for these neoplasms has been adopted in Brazil.…”

Section: Discussionmentioning

confidence: 92%

Trends in cancer mortality in Brazil, 1980–2004

Chatenoud

Bertuccio²,

Bosetti

et al. 2010

European Journal of Cancer Prevention

Self Cite

View full text Add to dashboard Cite

Scanty information, limited to selected areas of the country, is available on cancer mortality in Brazil. Age-standardized (world population) mortality rates between 1980 and 2004, derived from the WHO database, were computed for all cancers and 24 major cancer sites in Brazil. Joinpoint regression analyses were used to identify the significant changes in trends and estimate annual percent change (APC) in rates. Total cancer mortality rates increased over the last decade in men (APC = 0.5) to reach 101.2/100 000, and in women (APC = 0.3) to reach 71.3/100 000. In men, upward trends were observed for cancers of the oral cavity and pharynx with a rate of 5.9/100 000 in 2000-2004, intestines (whose rate, however was low, i.e. 7.6), prostate (12.2), and leukemias (3.4). Male lung cancer increased until 1993 (APC = 1.39) and decreased thereafter (APC = -0.29), with a relatively low rate of 16.2/100 000 in 2000-2004. In women, there were steady upward trends for cancers of the lung (APC = 2.3), reaching 6.2/100 000 in 2000-2004, and leukemias (2.5). Breast cancer mortality leveled off at around 10/100 000 in the last decade, whereas declines were observed for cancers of the uterus, whose rate (8.3) however, remained comparatively high. Declines were observed for stomach cancer in both sexes, with rates of 11.1 in men and 4.6 in women. In conclusion, the key issues of cancer mortality in Brazil are the high rates of head and neck cancers in men and (cervix) uterine cancer in women, that is, in principle cancers that are largely avoidable through prevention, screening, and early diagnosis.

show abstract

Testicular cancer mortality in the Americas, 1980–2003

Cited by 29 publications

References 43 publications

Overuse of Cigarettes Smoking and Link with Urologic Disease

Overuse of Cigarettes Smoking and Link with Urologic Disease

Hodgkin's lymphoma mortality in the Americas, 1997–2008: Achievements and persistent inadequacies

Trends in cancer mortality in Brazil, 1980–2004

Contact Info

Product

Resources

About